PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 93 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,381,239 | -35.8% | 82,809 | +6.3% | 0.00% | 0.0% |
Q2 2023 | $2,151,901 | +125156.2% | 77,911 | +4.3% | 0.00% | 0.0% |
Q1 2023 | $1,718 | +121.4% | 74,709 | +5.0% | 0.00% | +100.0% |
Q4 2022 | $776 | -99.9% | 71,153 | +0.9% | 0.00% | 0.0% |
Q3 2022 | $594,000 | +12.7% | 70,517 | +5.9% | 0.00% | 0.0% |
Q2 2022 | $527,000 | -52.0% | 66,566 | +43.4% | 0.00% | 0.0% |
Q1 2022 | $1,099,000 | -26.9% | 46,426 | +5.6% | 0.00% | -50.0% |
Q4 2021 | $1,504,000 | +98.7% | 43,969 | +3.0% | 0.00% | +100.0% |
Q3 2021 | $757,000 | -58.7% | 42,695 | +4.6% | 0.00% | -50.0% |
Q2 2021 | $1,832,000 | +113.0% | 40,812 | +22.9% | 0.00% | +100.0% |
Q1 2021 | $860,000 | +26.5% | 33,215 | -1.5% | 0.00% | 0.0% |
Q4 2020 | $680,000 | +18.1% | 33,735 | +14.6% | 0.00% | 0.0% |
Q3 2020 | $576,000 | +9.9% | 29,446 | -0.8% | 0.00% | 0.0% |
Q2 2020 | $524,000 | +344.1% | 29,676 | +78.0% | 0.00% | – |
Q1 2020 | $118,000 | +2.6% | 16,671 | +2.3% | 0.00% | – |
Q4 2019 | $115,000 | -38.5% | 16,291 | +4.8% | 0.00% | – |
Q3 2019 | $187,000 | +19.9% | 15,540 | +20.7% | 0.00% | – |
Q2 2019 | $156,000 | +77.3% | 12,878 | +25.1% | 0.00% | – |
Q1 2018 | $88,000 | -50.6% | 10,294 | +2.0% | 0.00% | – |
Q3 2017 | $178,000 | +56.1% | 10,096 | +0.2% | 0.00% | – |
Q2 2017 | $114,000 | – | 10,076 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |